Ramipril

angiotensin I converting enzyme ; Homo sapiens







272 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
201 10170450 Cost effectiveness in the treatment of heart failure with ramipril. A Swedish substudy of the AIRE study. Acute Infarction Ramipril Efficacy. 1997 Aug 1
202 8771657 [The efficacy of treatment with the angiotensin-converting enzyme inhibitor ramipril in patients with congestive heart failure of rheumatic etiology]. 1996 1
203 8834929 Mega-trials: is meta-analysis an alternative? 1996 1
204 8902551 Interruption of prolonged ramipril treatment in hypertensive patients: effects on the renin-angiotensin system. 1996 1
205 8908384 Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention Evaluation. 1996 Nov 1
206 9081852 The DIAB-HYCAR Study. 1996 Dec 1
207 7585774 Angiotensin-converting enzyme inhibitors post-myocardial infarction. 1995 Aug 1
208 7607751 Long term effects of ACE inhibitors on the erythrocytosis in renal transplant recipients. 1995 Jan 1
209 7768254 Pharmacokinetics, pharmacodynamics and bioavailability of the ACE inhibitor ramipril. 1995 2
210 7774515 Ramipril. An updated review of its therapeutic use in essential hypertension and heart failure. 1995 Mar 3
211 7786840 Reduction of ischemic events with angiotensin-converting enzyme inhibitors: lessons and controversy emerging from recent clinical trials. 1995 Feb 1
212 7787145 The study of the effect of intensity of blood pressure management on the progression of type 1 diabetic nephropathy: study design and baseline patient characteristics. Collaborative Study Group. 1995 Apr 1
213 8617412 Role of the renin-angiotensin system in systemic and regional vascular responses to orthostatic stress in healthy volunteers. 1995 2
214 8682064 Neurohormonal activation and congestive heart failure: today's experience with ACE inhibitors and rationale for their use. 1995 Dec 1
215 8984131 ACE inhibitor ramipril is more effective than the beta-blocker atenolol in reducing left ventricular mass in hypertension. Results of the RACE (ramipril cardioprotective evaluation) study on behalf of the RACE study group. 1995 Nov 2
216 11850671 Efficacy and Safety of Ramipril in Hypertensive Single-Kidney Patients. 1995 May 1
217 7857733 Influence of angiotensin converting enzyme inhibition on relation of atrial natriuretic peptide concentration to atrial pressure in heart failure. 1994 Dec 1
218 7868871 Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension? 1994 Nov 2
219 8042078 The Grande Roche ACE debate. 1994 Feb 1
220 8137599 Clinical pharmacokinetics of ramipril. 1994 Jan 1
221 8205743 Response of plasma neuropeptide Y and noradrenaline to dynamic exercise and ramipril treatment in patients with congestive heart failure. 1994 Mar 1
222 7681510 Angiotensin converting enzyme inhibition does not prevent the natriuretic effect of felodipine. 1993 Mar 2
223 8117516 [Rational criteria for the choice of ACE inhibitor adapted to the individual hypertensive patient]. 1993 Oct 1
224 8276048 Acute haemodynamic effects and pharmacokinetics of ramipril in patients with heart failure. A placebo controlled three-dose study. 1993 2
225 8299664 The acute haemodynamic and renal effects of oral felodipine and ramipril in healthy subjects. 1993 1
226 8321736 Comparison of ramipril and enalapril in patients with essential hypertension. 1993 May-Jun 5
227 1282625 Effect of bradykinin on arteries and veins in systemic and pulmonary circulation. 1992 1
228 1329465 Drug-patient interactions and their relevance in the treatment of heart failure. 1992 Oct 8 2
229 1411408 [Monotherapy with the ACE-inhibitor ramipril or the calcium antagonist nitrendipine in essential hypertension]. 1992 Oct 3 1
230 1532570 Ramipril: a review of the new ACE inhibitor. 1992 Feb 3
231 1535400 Is natriuresis on felodipine due to reversal of the renal effects of angiotensin II? 1992 May 2
232 1646621 A study of the acute pharmacodynamic interaction of ramipril and felodipine in normotensive subjects. 1991 Feb 1
233 1650862 [Effects of the angiotensin converting enzyme inhibitor ramipril on calcium (Ca2+) kinetics in smooth muscle cells]. 1991 2
234 1661764 Inhibition of angiotensin converting enzyme by ramipril in serum and tissue of man. 1991 Nov 5
235 1725019 Effect of angiotensin-converting enzyme inhibition on human tissue renin. 1991 4
236 1725027 Comparison of response rates to the angiotensin-converting enzyme inhibitor ramipril in mild-to-moderate hypertension in a double-blind, parallel-group study and an open single-blind study. 1991 2
237 1725028 Efficacy and safety of a new angiotensin-converting enzyme inhibitor, ramipril, vs. enalapril in essential hypertension: a multicenter trial. 1991 1
238 1725030 Effects of ramipril on arterial hemodynamics. 1991 2
239 1834452 More ACE inhibitors--quinapril, perindopril & ramipril. 1991 Apr 15 1
240 1837563 Long lasting arterial effects of the ACE inhibitor ramipril. 1991 Oct 3
241 2138076 Ramipril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders. 1990 Jan 4
242 2138704 [Acute effects of the angiotensin converting enzyme inhibitor ramipril in patients with coronary heart disease]. 1990 Feb 15 4
243 2141472 Metabolic effects of ramipril treatment in hypertensive subjects with non-insulin-dependent diabetes mellitus. 1990 Apr 1
244 2143594 [Tissue renin-angiotensin system. Physiology and physiopathological value of their inhibition by ramipril]. 1990 Jun 21 1
245 2147879 Physicochemical and enzyme binding kinetic properties of a new angiotensin-converting enzyme inhibitor ramipril and their clinical implications. 1990 3
246 2226219 Angiotensin converting enzyme inhibitors and moderate hypertension. 1990 Sep 1
247 2257720 Angiotensin-converting enzyme inhibition in patients with essential hypertension. 1990 1
248 2474101 Pharmacodynamic effects of a single 10-mg dose of the angiotensin converting enzyme inhibitor ramipril in patients with impaired renal function. 1989 4
249 2474102 Pharmacokinetic and pharmacodynamic properties of ramipril in patients with congestive heart failure (NYHA III-IV). 1989 4
250 2474105 Therapeutic efficacy and tolerance of ramipril in hypertensive patients with renal failure. 1989 1